q1y17earnings_image2a03.jpg

FOR IMMEDIATE RELEASE
 
CONTACT:
Lisa Miles 703.251.8637
 
 
 
lisamiles@maximus.com
Date: May 4, 2017
 
 
 

MAXIMUS Reports Second Quarter Results
- Raises Lower End of Full-Year Earnings Guidance and
Maintains Revenue Guidance for Fiscal Year 2017 -


(RESTON, Va. - May 4, 2017) - MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, today reported financial results for the three and six months ended March 31, 2017.

Highlights for the second quarter of fiscal year 2017 include:

Revenue growth of 3% to $622.0 million compared to the same period last year

Diluted earnings per share of $0.80 compared to $0.74 for the same period last year

Strong cash flow with cash from operations of $65.7 million and free cash flow of $60.5 million

Year-to-date signed contract awards of $1.5 billion and contracts pending (awarded but unsigned) of
$155.1 million at March 31, 2017

Sales pipeline of $3.3 billion at March 31, 2017

Updated fiscal 2017 earnings guidance now expected to range between $3.00 and $3.10

For the second quarter of fiscal 2017, revenue increased 3% to $622.0 million compared to $606.5 million reported for the same period last year driven by the Health Services Segment. Most of the revenue growth in the quarter was organic, which was partially offset by a 2% decline from unfavorable foreign currency translation. On a constant currency basis, revenue would have increased 4% compared to the same period last year.

Total company operating margin for the second quarter of fiscal 2017 was 12.9% compared to 12.8% for the same period last year.

For the second quarter of fiscal 2017, net income attributable to MAXIMUS totaled $52.5 million (or $0.80 of diluted earnings per share). This was better than expected, driven by favorable results on several volume-based contracts in both the U.S. Federal Services and Health Services segments. This compares to diluted earnings per share of $0.74 for the second quarter of fiscal 2016, which benefited from out-of-period revenue and pre-tax income of $15.2 million (or $0.16 of diluted earnings per share) from two previously disclosed contract amendments in the Health Services Segment.



1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 1


q1fy17earnings_image1a03.jpg


Health Services Segment
Health Services Segment revenue for the second quarter of fiscal 2017 increased 6% to $349.0 million compared to $330.6 million reported for the same period last year. Most of the growth in the quarter was organic, which was offset by a 3% decline from unfavorable foreign currency translation. On a constant currency basis, revenue growth would have been 9%.

Operating margin for the second quarter of fiscal 2017 was 16.2% compared to 17.2% reported in the prior-year period.

As previously disclosed, the second quarter of last year benefited from $15.2 million of out-of-period revenue and pre-tax income related to two items: an $8.6 million change order on a large U.S. contract and $6.6 million resulting from contract modifications on the U.K. Health Assessment Advisory Service.

U.S. Federal Services Segment
U.S. Federal Services Segment revenue for the second quarter of fiscal 2017 decreased 3% to $145.4 million compared to $150.2 million reported for the same period last year. As previously disclosed, the lower revenue was largely a result of a contract cancellation for a program with the U.S. Department of Veterans Affairs. This contract ended in April of this year.

Operating margin for the second quarter was 12.1% compared to 10.0% reported for the prior-year period. The margin expansion was driven by favorable results from several volume-based contracts.

Human Services Segment
Human Services Segment revenue for the second quarter of fiscal 2017 increased 2% to $127.7 million compared to $125.7 million for the same period last year. Nearly all growth in the quarter was organic, which was partially offset by expected decreases in the Company's United Kingdom operations. The anticipated ramp down of the U.K. Work Programme unfavorably impacted both revenue and operating income in the second quarter of fiscal 2017.

Operating margin for the second quarter was 7.5% and comparable to 7.8% for the same period last year.

Sales and Pipeline
Year-to-date signed contract awards at March 31, 2017 totaled $1.5 billion and includes a three-year contract extension with the State of New York. In addition, contracts pending (awarded but unsigned) totaled
$155.1 million.

The sales pipeline at March 31, 2017 was $3.3 billion (comprised of approximately $0.6 billion in proposals pending, $0.9 billion in proposals in preparation, and $1.9 billion in opportunities tracking). This compares to a pipeline of $4.0 billion at December 31, 2016. The sequential decline is principally due to contracts converting to new awards and, to a lesser extent, procurement delays, contract losses, cancellations and no bids.

Balance Sheet and Cash Flows
Cash and cash equivalents at March 31, 2017 totaled $94.9 million. For the three months ended March 31, 2017, cash flows from operations totaled $65.7 million, with free cash flow of $60.5 million.

At March 31, 2017, Days Sales Outstanding (DSOs) were 69 and within the Company’s expected range.

On February 28, 2017, MAXIMUS paid a quarterly cash dividend of $0.045 per share. On April 11, 2017, the Company announced a $0.045 per share cash dividend, payable on May 31, 2017 to shareholders of record on May 15, 2017.


1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 2


q1fy17earnings_image1a03.jpg


Outlook
MAXIMUS is raising the bottom end of its fiscal 2017 earnings guidance and now expects GAAP diluted earnings per share to range between $3.00 and $3.10 for fiscal 2017. This compares to the Company's prior range of $2.90 to $3.10.

MAXIMUS is reiterating its revenue guidance and continues to expect revenue to range between $2.425 billion and $2.475 billion for fiscal 2017. The Company is also reiterating its cash flow guidance and continues to expect cash flows from operations to range between $230 million and $280 million and free cash flow to range between $170 million and $220 million for fiscal 2017. The Company’s guidance does not include any future acquisitions or future legal expenses or recoveries.

"We are pleased to be raising the lower end of our earnings guidance for fiscal year 2017 as a result of good performance and some expected tax benefits," commented MAXIMUS CEO Richard A. Montoni. "In addition, the extension of our contract with New York through 2020 is confirmation of our pledge to continue providing high-quality services to the state. During the quarter, we closed out contract year two of the U.K. Health Assessment Advisory Service. We successfully completed more than a million assessments in our second contract year, and we remain on track to achieve our financial and operational objectives for this program."

Conference Call and Webcast Information
MAXIMUS will host a conference call this morning, May 4, 2017, at 9:00 a.m. (ET). The call is open to the public and is available by webcast at http://investor.maximus.com or by phone at:
    
877.407.8289 (Domestic)/+1.201.689.8341 (International)

For those unable to listen to the live call, a replay will be available through May 18, 2017. Callers can access the replay by calling:

877.660.6853 (Domestic)/+1.201.612.7415 (International)
Replay conference ID number: 13660023

About MAXIMUS
Since 1975, MAXIMUS has operated under its founding mission of Helping Government Serve the People®, enabling citizens around the globe to successfully engage with their governments at all levels and across a variety of health and human services programs. MAXIMUS delivers innovative business process management and technology solutions that contribute to improved outcomes for citizens and higher levels of productivity, accuracy, accountability and efficiency of government-sponsored programs. With more than 18,000 employees worldwide, MAXIMUS is a proud partner to government agencies in the United States, Australia, Canada, Saudi Arabia and the United Kingdom. For more information, visit maximus.com.

Non-GAAP Measures
We utilize non-GAAP measures where we believe it will assist the user of our financial statements in understanding our business. The presentation of these measures is meant to complement, and not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to revenue growth, cash flows from operations or net income as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.



1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 3


q1fy17earnings_image1a03.jpg


In this press release, we use the non-GAAP measures of organic revenue growth, constant currency movement and free cash flow. A description of these measures, including a description of our use of these measures and our methodology for calculating them, is included in our most recent Annual Report on Form
10-K, filed with the Securities and Exchange Commission on November 21, 2016. We have included a reconciliation of free cash flow to cash flows from operations in this press release.

Statements that are not historical facts, including statements about the Company’s confidence and strategies and the Company’s expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand or acceptance of the Company’s products are forward-looking statements that involve risks and uncertainties. These uncertainties could cause the Company’s actual results to differ materially from those indicated by such forward-looking statements and include reliance on government clients; risks associated with government contracting; risks involved in managing government projects; legislative changes and political developments; opposition from government unions; challenges resulting from growth; adverse publicity; and legal, economic, and other risks detailed in Exhibit 99.1 to the Company’s most recent Annual Report filed with the Securities and Exchange Commission, found on maximus.com.




1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 4


q1fy17earnings_image1a03.jpg


MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except per share data)
(Unaudited)

 
Three Months Ended March 31,
 
Six Months Ended March 31,
 
2017
 
2016
 
2017
 
2016
Revenue
$
622,047

 
$
606,453

 
$
1,229,611

 
$
1,163,175

Cost of revenue
469,730

 
458,786

 
932,476

 
905,293

Gross profit
152,317

 
147,667

 
297,135

 
257,882

Selling, general and administrative expenses
68,596

 
65,976

 
133,994

 
130,210

Amortization of intangible assets
3,386

 
3,262

 
6,788

 
6,411

Restructuring costs

 

 
2,242

 

Acquisition-related expenses

 
529

 

 
575

Operating income
80,335

 
77,900

 
154,111

 
120,686

Less:
 
 
 
 
 
 
 
Interest expense
744

 
1,273

 
1,593

 
2,262

Add:
 
 
 
 
 
 
 
Other income, net
417

 
2,209

 
680

 
3,340

Income before income taxes
80,008

 
78,836

 
153,198

 
121,764

Provision for income taxes
26,911

 
29,495

 
53,772

 
45,541

Net income
53,097

 
49,341

 
99,426

 
76,223

Income attributable to noncontrolling interests
582

 
556

 
247

 
829

Net income attributable to MAXIMUS
$
52,515

 
$
48,785

 
$
99,179

 
$
75,394

Basic earnings per share attributable to MAXIMUS
$
0.80

 
$
0.74

 
$
1.51

 
$
1.14

Diluted earnings per share attributable to MAXIMUS
$
0.80

 
$
0.74

 
$
1.50

 
$
1.14

Dividends paid per share
$
0.045

 
$
0.045

 
$
0.09

 
$
0.09

Weighted average shares outstanding:
 
 
 
 

 
 
Basic
65,549

 
65,760

 
65,669

 
65,872

Diluted
65,947

 
66,079

 
65,989

 
66,196














1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 5


q1fy17earnings_image1a03.jpg


MAXIMUS, Inc.
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
 
March 31, 2017
 
September 30, 2016
 
(unaudited)
 
 
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
94,862

 
$
66,199

Accounts receivable — billed and billable
432,255

 
444,357

Accounts receivable  unbilled
39,878

 
36,433

Income taxes receivable
524

 
17,273

Prepaid expenses and other current assets
50,442

 
56,718

Total current assets
617,961

 
620,980

Property and equipment, net
112,882

 
131,569

Capitalized software, net
27,564

 
30,139

Goodwill
395,011

 
397,558

Intangible assets, net
101,645

 
109,027

Deferred contract costs, net
16,917

 
18,182

Deferred compensation plan assets
25,805

 
23,307

Deferred income taxes
8,791

 
8,644

Other assets
9,910

 
9,413

Total assets
$
1,316,486

 
$
1,348,819

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable and accrued liabilities
$
130,537

 
$
150,711

Accrued compensation and benefits
80,636

 
96,480

Deferred revenue
63,533

 
73,692

Income taxes payable
11,870

 
7,979

Long-term debt, current portion
217

 
277

Other liabilities
11,582

 
11,617

Total current liabilities
298,375

 
340,756

Deferred revenue, less current portion
32,902

 
40,007

Deferred income taxes
10,550

 
16,813

Long-term debt
115,559

 
165,338

Deferred compensation plan liabilities, less current portion
26,950

 
24,012

Other liabilities
8,740

 
8,753

Total liabilities
493,076

 
595,679

Shareholders’ equity:
 
 
 
Common stock, no par value
472,075

 
461,679

Accumulated other comprehensive loss
(40,235
)
 
(36,169
)
Retained earnings
387,881

 
323,571

Total MAXIMUS shareholders’ equity
819,721

 
749,081

Noncontrolling interests
3,689

 
4,059

Total equity
823,410

 
753,140

Total liabilities and equity
$
1,316,486

 
$
1,348,819



1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 6


q1fy17earnings_image1a03.jpg


MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited)
 
 
Three Months Ended March 31,
 
Six Months Ended March 31,
 
 
2017
 
2016
 
2017
 
2016
Cash flows from operations:
 
 
 
 
 
 
 
 
Net income
 
$
53,097

 
$
49,341

 
$
99,426

 
$
76,223

Adjustments to reconcile net income to cash flows from operations:
 
 
 
 
 
 
 
 
Depreciation and amortization of property, equipment and capitalized software
 
15,405

 
12,912

 
29,967

 
25,859

Amortization of intangible assets
 
3,386

 
3,262

 
6,788

 
6,411

Deferred income taxes
 
(11,631
)
 
172

 
(5,721
)
 
(327
)
Stock compensation expense
 
5,345

 
4,819

 
10,234

 
9,151

 
 
 
 
 
 
 
 
 
Change in assets and liabilities:
 
 
 
 
 
 
 
 
Accounts receivable — billed and billable
 
(4,657
)
 
(5,304
)
 
10,030

 
(35,051
)
Accounts receivable — unbilled
 
(1,447
)
 
(2,998
)
 
(3,445
)
 
(4,851
)
Prepaid expenses and other current assets
 
1,267

 
127

 
7,512

 
5,443

Deferred contract costs
 
954

 
46

 
998

 
810

Accounts payable and accrued liabilities
 
(3,144
)
 
(28,137
)
 
(17,719
)
 
(19,949
)
Accrued compensation and benefits
 
10,944

 
7,172

 
(6,293
)
 
(14,211
)
Deferred revenue
 
(5,757
)
 
877

 
(15,853
)
 
(2,009
)
Income taxes
 
3,813

 
(19,554
)
 
20,715

 
(22,597
)
Other assets and liabilities
 
(1,867
)
 
(2,237
)
 
209

 
(3,038
)
Cash flows from operations
 
65,708

 
20,498

 
136,848

 
21,864

 
 
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
 
 
Purchases of property and equipment and capitalized software costs
 
(5,207
)
 
(9,151
)
 
(12,975
)
 
(19,836
)
Acquisition of businesses, net of cash acquired
 

 
(39,206
)
 

 
(41,812
)
Proceeds from the sale of a business
 

 

 
385

 

Other
 
175

 
126

 
218

 
210

Cash used in investing activities
 
(5,032
)
 
(48,231
)
 
(12,372
)
 
(61,438
)
 
 
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
 
 
Cash dividends paid to MAXIMUS shareholders
 
(2,917
)
 
(2,919
)
 
(5,837
)
 
(5,860
)
Repurchases of common stock
 
(91
)
 

 
(28,858
)
 
(31,138
)
Tax withholding related to RSU vesting
 
(12
)
 
(44
)
 
(9,267
)
 
(11,597
)
Borrowings under credit facility
 
70,000

 
83,493

 
135,000

 
130,563

Repayment of credit facility and other long-term debt
 
(104,761
)
 
(42,498
)
 
(184,828
)
 
(55,219
)
Other
 

 

 
(1,145
)
 

Cash (used in)/provided by financing activities
 
(37,781
)
 
38,032

 
(94,935
)
 
26,749

 
 
 
 
 
 
 
 
 
Effect of exchange rate changes on cash and cash equivalents
 
2,200

 
(474
)
 
(878
)
 
(1,064
)
 
 
 
 
 
 
 
 
 
Net increase/(decrease) in cash and cash equivalents
 
25,095

 
9,825

 
28,663

 
(13,889
)
 
 
 
 
 
 
 
 
 
Cash and cash equivalents, beginning of period
 
69,767

 
50,958

 
66,199

 
74,672

 
 
 
 
 
 
 
 
 
Cash and cash equivalents, end of period
 
$
94,862

 
$
60,783

 
$
94,862

 
$
60,783

 
 


 
 
 
 
 
 


1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 7


q1fy17earnings_image1a03.jpg



MAXIMUS, Inc.
SEGMENT INFORMATION
(Amounts in thousands)
(Unaudited)
 
 
Three Months Ended March 31,
 
Six Months Ended March 31,
(Amounts in thousands)
 
2017
 
% (1)
 
2016
 
% (1)
 
2017
 
% (1)
 
2016
 
% (1)
Revenue:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health Services
 
$
348,994

 
100
%
 
$
330,567

 
100
%
 
$
689,723

 
100
%
 
$
622,470

 
100
%
U.S. Federal Services
 
145,370

 
100
%
 
150,191

 
100
%
 
286,668

 
100
%
 
295,476

 
100
%
Human Services
 
127,683

 
100
%
 
125,695

 
100
%
 
253,220

 
100
%
 
245,229

 
100
%
Total
 
$
622,047

 
100
%
 
$
606,453

 
100
%
 
$
1,229,611

 
100
%
 
$
1,163,175

 
100
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross Profit:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health Services
 
$
86,454

 
24.8
%
 
$
82,717

 
25.0
%
 
$
164,688

 
23.9
%
 
$
134,689

 
21.6
%
U.S. Federal Services
 
36,571

 
25.2
%
 
33,421

 
22.3
%
 
74,147

 
25.9
%
 
61,659

 
20.9
%
Human Services
 
29,292

 
22.9
%
 
31,529

 
25.1
%
 
58,300

 
23.0
%
 
61,534

 
25.1
%
Total
 
$
152,317

 
24.5
%
 
$
147,667

 
24.3
%
 
$
297,135

 
24.2
%
 
$
257,882

 
22.2
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Selling, general, and administrative expense:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health Services
 
$
29,914

 
8.6
%
 
$
25,803

 
7.8
%
 
$
58,021

 
8.4
%
 
$
50,967

 
8.2
%
U.S. Federal Services
 
18,927

 
13.0
%
 
18,438

 
12.3
%
 
38,622

 
13.5
%
 
35,960

 
12.2
%
Human Services
 
19,663

 
15.4
%
 
21,735

 
17.3
%
 
36,902

 
14.6
%
 
42,633

 
17.4
%
Other (4)
 
92

 
NM

 

 
NM

 
449

 
NM

 
650

 
NM

Total
 
$
68,596

 
11.0
%
 
$
65,976

 
10.9
%
 
$
133,994

 
10.9
%
 
$
130,210

 
11.2
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health Services
 
$
56,540

 
16.2
%
 
$
56,914

 
17.2
%
 
$
106,667

 
15.5
%
 
$
83,722

 
13.4
%
U.S. Federal Services
 
17,644

 
12.1
%
 
14,983

 
10.0
%
 
35,525

 
12.4
%
 
25,699

 
8.7
%
Human Services
 
9,629

 
7.5
%
 
9,794

 
7.8
%
 
21,398

 
8.5
%
 
18,901

 
7.7
%
Amortization of intangible assets
 
(3,386
)
 
NM

 
(3,262
)
 
NM

 
(6,788
)
 
NM

 
(6,411
)
 
NM

Restructuring costs (2)
 

 
NM

 

 
NM

 
(2,242
)
 
NM

 

 
NM

Acquisition-related expenses (3)
 

 
NM

 
(529
)
 
NM

 

 
NM

 
(575
)
 
NM

Other (4)
 
(92
)
 
NM

 

 
NM

 
(449
)
 
NM

 
(650
)
 
NM

Total
 
$
80,335

 
12.9
%
 
$
77,900

 
12.8
%
 
$
154,111

 
12.5
%
 
$
120,686

 
10.4
%

(1)    Percentage of respective segment revenue. Percentages not considered meaningful are marked “NM.”
(2)
During the current fiscal year, we incurred costs in restructuring our United Kingdom Human Services business.
(3)
Acquisition-related expenses relate to the acquisitions of Assessments Australia and Ascend in December 2015 and February 2016, respectively.
(4) 
During the six months ended March 31, 2017, we incurred $0.4 million of legal-related costs pertaining to a legacy matter from a business line that the Company exited. During the six months ended March 31, 2016, we incurred $0.7 million of legal costs related to a matter that occurred in fiscal year 2014. Both items are classified within other selling general and administrative expense.



1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 8


q1fy17earnings_image1a03.jpg


MAXIMUS, Inc.
FREE CASH FLOW
(Non-GAAP measure)
(Amounts in thousands)
(Unaudited)

 
 
Three Months Ended March 31,
 
Six Months Ended March 31,
(in thousands)
 
2017
 
2016
 
2017
 
2016
Cash provided by operating activities
 
$
65,708

 
$
20,498

 
$
136,848

 
$
21,864

Purchases of property and equipment and capitalized software costs
 
(5,207
)
 
(9,151
)
 
(12,975
)
 
(19,836
)
Free cash flow
 
$
60,501

 
$
11,347

 
$
123,873

 
$
2,028

 
 
 
 
 
 
 
 
 



-XXX-


1891 METRO CENTER DRIVE | RESTON, VIRGINIA 20190 | 703.251.8500 | MAXIMUS.COM

Page 9